港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物医药B类股

661.647

+7.4121.13%

涨家数：19

跌家数：14

平家数：1

市盈率：- -

高：666.959

开：654.173

低：636.061

收：654.235

成交量：9,431.67万

成交额：30.85亿

市值：4,212.01亿

流通市值：3,756.38亿

数据加载中...

总览新闻资讯

制药巨头警告：欧洲可能沦为制药行业的“销售办事处”

腾盛博药-B(02137)在APASL 2026发表治疗结束后HBsAg反弹的跨研究分析结果

GLP-1赛道全球竞速，一家张江创新药企的海外突围

前新财富医药“一姐”张明芳控诉杭州德诺电生理，索要关键协议原件15个月未果！超6亿元股权交易之争牵扯多家国资背景基金、知名创投及上市公司

每日经济新闻

告别乙流多次服药！健康元创新药玛帕西沙韦胶囊或成更优选择

诺诚健华(09969)授出1538.92万份受限制股份单位

归创通桥(02190)4月24日斥资114.06万港元回购5万股

诺诚健华：公司预计2026年药品销售收入将继续稳健增长

汇添富基金增持荣昌生物(09995)7.9万股每股作价约113.78港元

智通财经网

港股异动 | 凯莱英(06821)午后涨近6% 20亿元化学大分子创新药CDMO项目落地天津经开区

创新药概念持续拉升海西新药(02637)领涨12.77%、歌礼制药-B(01672)涨6.27%

劲方医药-B午前涨超7% 两项GFH375/VS-7375临床前研究入选突破性研究摘要

中国抗体－Ｂ(03681)股价下跌5.161%，现价港币$1.47

阿斯达克财经

创新药板块获资金大举逆势布局！恒生创新药ETF华泰柏瑞（520500）成交放量，昨日成交环比增长超60%

港股异动 | 歌礼制药-B(01672)午前涨超4% 核心管线ASC30即将启动III期注册临床

什么情况？港股通创新药突遭重挫，龙头领跌12%！520880放量跌4.51%连失多根均线，加仓还是离场？

【湾区早参】香港最新失业率下跌至3.7%；一季度深圳口岸累计出入境人员超7300万人次

男子称用了10多年的学位证被告知“无效” 山东医药大学：正调查核实

中国创新药“军团”领跑AACR年会

21世纪经济报道

加科思-B(01167)4月23日耗资约49.45万港元回购6.75万股

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK1574/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物医药B类股","latestPrice":661.64685,"timestamp":1777018105801,"preClose":654.2346,"halted":0,"volume":94316735,"delay":0,"changeRate":0.01133,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":7.412231,"latestTime":"04-24 16:00:00","open":654.17346,"high":666.9594,"low":636.06134,"amount":3085297395,"amplitude":0.047228,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"pbRate":5.188237,"peRate":-88.006625,"turnoverRate":0.00339,"increases":18,"decrements":14,"flats":1,"marketCap":421200541216,"floatMarketCap":375638141760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":666.9594,"amplitude":0.047228,"preClose":654.2346,"low":636.06134,"pbRate":"5.188237","latestPrice":661.64685,"volume":94316735,"delay":0,"open":654.17346,"prevYearClose":556.26263,"prevWeekClose":719.918,"prevMonthClose":610.821,"prevQuarterClose":610.821,"fiveDayClose":719.918,"twentyDayClose":567.335,"sixtyDayClose":569.48,"secType":"PLATE","market":"HK","turnoverRate":0.00339,"peRate":-88.006625,"marketCap":421200541216,"floatMarketCap":375638141760,"timestamp":1777018105801,"nameCN":"生物医药B类股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":19,"down":14,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630678338","title":"制药巨头警告：欧洲可能沦为制药行业的“销售办事处”","url":"https://stock-news.laohu8.com/highlight/detail?id=2630678338","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630678338?lang=zh_cn&edition=fundamental","pubTime":"2026-04-26 22:47","pubTimestamp":1777214868,"startTime":"0","endTime":"0","summary":"瑞士制药巨头罗氏CEO托马斯·施内克（ThomasSchinecker）近日警告称，欧洲在药物研发和创新方面可能进一步落后于美国和中国。根据研究公司GlobalData的一项最新数据分析，自去年5月美国药品降价政策实施以来，欧洲新药在美国上市数量下降了约三分之一。施内克表示：“欧洲正在包括创新药在内的大多数行业落后，我们已经输掉了竞赛，即便生物医药行业是欧洲传统的优势行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604263719393530.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604263719393530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01477","BK1574","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630382242","title":"腾盛博药-B(02137)在APASL 2026发表治疗结束后HBsAg反弹的跨研究分析结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2630382242","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630382242?lang=zh_cn&edition=fundamental","pubTime":"2026-04-26 19:03","pubTimestamp":1777201422,"startTime":"0","endTime":"0","summary":"智通财经APP讯，腾盛博药-B 发布公告，本公司在2026年4月22至25日于土耳其伊斯坦布尔举行的第35届亚太肝病学会年会上，发表了一项关于治疗后乙肝表面抗原反弹特征的跨研究汇总分析结果。本次分析对两项研究的数据进行了汇总，以评估接受PEG-IFNα单药或联合 elebsiran或BRII-179治疗的参与者在EOT后HBsAg反弹的发生率、反弹幅度以及其临床相关性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02137","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630180040","title":"GLP-1赛道全球竞速，一家张江创新药企的海外突围","url":"https://stock-news.laohu8.com/highlight/detail?id=2630180040","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630180040?lang=zh_cn&edition=fundamental","pubTime":"2026-04-26 07:44","pubTimestamp":1777160682,"startTime":"0","endTime":"0","summary":"一家来自中国的生物医药企业跑到地球另一端的巴西注册创新药，这样一段跨越近两万公里的出海之旅能走通吗？在没有先例的情况下，驻扎在上海浦东的银诺医药“第一个吃螃蟹”。最新消息传来：企业核心产品——依苏帕格鲁肽α最快有望一年后在巴西实现上市。从产品创新到全球布局——上海生物医药产业规模去年首次突破万亿元大关的同时，海外授权许可交易数量达48起，同比增长55%，为全国第一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604263719165143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","06978","159992","BK4144","BK4590","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630280894","title":"前新财富医药“一姐”张明芳控诉杭州德诺电生理，索要关键协议原件15个月未果！超6亿元股权交易之争牵扯多家国资背景基金、知名创投及上市公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2630280894","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630280894?lang=zh_cn&edition=fundamental","pubTime":"2026-04-25 18:19","pubTimestamp":1777112391,"startTime":"0","endTime":"0","summary":"近日，投资圈流传出一份由杭州德诺电生理医疗科技有限公司（以下简称德诺电生理）股东发出的公开信，信中针对德诺电生理的控制权转让交易提出多项质疑。《每日经济新闻》记者（以下简称每经记者）获悉，该文章的作者正是前新财富医药“一姐”——两次获得新财富医药生物行业最佳分析师评选第一名的张明芳。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604253719071292.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604253719071292.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","09939","BK1161","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630875040","title":"告别乙流多次服药！健康元创新药玛帕西沙韦胶囊或成更优选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2630875040","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630875040?lang=zh_cn&edition=fundamental","pubTime":"2026-04-25 08:24","pubTimestamp":1777076695,"startTime":"0","endTime":"0","summary":"近期，全国流感活动持续攀升，乙型流感强势主导本轮流行季，对公众健康构成显著威胁。中国疾控中心近期发布的全国急性呼吸道传染病哨点监测数据显示，全国流感病毒检测阳性率连续几周上升，北方省份检测阳性率高于南方。　　目前，据了解玛帕西沙韦胶囊已在各大主流医药电商平台上线，患者可便捷咨询购买，有效提升了药品可及性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/shichangjuejin/20260425/32173558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK0028","BK0114","BK0046","06978","BK0239","BK1574","159992","BK0188","600380","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629244844","title":"诺诚健华(09969)授出1538.92万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2629244844","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629244844?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 21:18","pubTimestamp":1777036724,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诺诚健华(09969)发布公告，于2026年4月24日，公司根据2023年股权激励计划向3名承授人授出1538.92万份受限制股份单位，相当于公司于本公告日期已发行股份总数(不包括库存股份)约0.87%。向相关执行董事授出受限制股份单位受限于及须待股东于应届股东周年大会批准后，方可作实。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1161","09969","688428","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629411348","title":"归创通桥(02190)4月24日斥资114.06万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629411348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629411348?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 20:47","pubTimestamp":1777034828,"startTime":"0","endTime":"0","summary":"智通财经APP讯，归创通桥(02190)发布公告，于2026年4月24日斥资114.06万港元回购5万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1100","BK1583","BK1587","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629084938","title":"诺诚健华：公司预计2026年药品销售收入将继续稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629084938","media":"证券日报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629084938?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 19:47","pubTimestamp":1777031220,"startTime":"0","endTime":"0","summary":"证券日报网4月24日讯，诺诚健华在接受调研者提问时表示，2026年第一季度，公司药品销售增长主要来自于核心产品奥布替尼持续放量、坦昔妥单抗和佐来曲替尼新增贡献，在三款产品组合驱动下，公司预计2026年药品销售收入将会继续稳健增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243718356725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","688428","BK1161","BK0239","09969"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629009846","title":"汇添富基金增持荣昌生物(09995)7.9万股 每股作价约113.78港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2629009846","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629009846?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 19:09","pubTimestamp":1777028987,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，4月22日，汇添富基金增持荣昌生物(09995)7.9万股，每股作价113.7788港元，总金额约为898.85万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260424/20260424191020_91579.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260424/20260424191020_91579.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","09995","LU2328871848.SGD","LU1064131003.USD","LU1064130708.USD","BK1574","LU2148510915.USD","LU1969619763.USD","BK1161","BK0239","688331","EWH","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629974938","title":"港股异动 | 凯莱英(06821)午后涨近6% 20亿元化学大分子创新药CDMO项目落地天津经开区","url":"https://stock-news.laohu8.com/highlight/detail?id=2629974938","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629974938?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 14:26","pubTimestamp":1777011981,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凯莱英午后涨近6%，截至发稿，涨5.49%，报97.1港元，成交额4458.26万港元。公开数据显示，2025年凯莱英化学大分子CDMO板块实现营业收入10.28亿元，同比增长123.72%，成为公司增长最为迅速的业务单元。公司预计26年多肽PPQ项目将达4个且多肽固相合成产能将从25年底的4.5万升增至26年底的6.9万升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK1574","BK4139","002821","BK0239","VXUS","159992","BK1161","06821","06978","BK4588","LU1328615791.USD","BK4585","BK1191","CDMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629894566","title":"创新药概念持续拉升 海西新药(02637)领涨12.77%、歌礼制药-B(01672)涨6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629894566","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629894566?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 13:11","pubTimestamp":1777007494,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念午后集体持续拉升，截至发稿，海西新药 涨12.77%，歌礼制药-B涨6.27%，诺诚健华涨5.18%，信达生物涨4.10%，科伦博泰生物涨2.84%，亚盛医药-B涨2.79%。西南证券亦表示，医药生物行业近期表现虽相对疲软，估值溢价率有所下降，但行业整体仍保持一定韧性。其他生物制品、医疗研发外包和原料药等细分领域表现突出，显示出医药创新和产业链优势的持续释放。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979909","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU0455707207.USD","LU2097828557.USD","LU2488822045.USD","06978","BK1161","LU2242644610.SGD","06990","LU2097828805.USD","09969","LU2097828631.EUR","06855","01672","159992","01477","LU2097828474.EUR","BK1589","LU0502904849.HKD","LU2097828714.EUR","BK1574","BK1191","LU2328871848.SGD","01801","BK1583","BK1515","02637","LU0196878994.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629899655","title":"劲方医药-B午前涨超7% 两项GFH375/VS-7375临床前研究入选突破性研究摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2629899655","media":"新浪港股","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629899655?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 11:50","pubTimestamp":1777002600,"startTime":"0","endTime":"0","summary":"　　劲方医药-B午前股价上涨7.34%，现报48.58港元，成交额5261.004万港元。　　4月23日，据劲方医药-B官微消息，公司宣布，GFH375/VS-7375多项临床前研究成果登陆2026年美国癌症研究协会年会壁报展示，其中两项研究数据入选突破性研究摘要。目前，GFH375/VS-7375多项单药和联合疗法试验正在国内外进行。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-04-24/doc-inhvqmqh4794330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","09939","BK1161","VS","159938","02595","BK1574","BK4085"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629899663","title":"中国抗体－Ｂ(03681)股价下跌5.161%，现价港币$1.47","url":"https://stock-news.laohu8.com/highlight/detail?id=2629899663","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629899663?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 11:45","pubTimestamp":1777002300,"startTime":"0","endTime":"0","summary":"[下跌股]中国抗体－Ｂ(03681) 股价在上午11:45比前收市价下跌5.161%，现股价为港币$1.47。至目前为止，今日最高价为$1.53，而最低价为$1.47。总成交量为189.75万股，总成交金额为港币$283.369万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2604242395/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2604242395/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629962048","title":"创新药板块获资金大举逆势布局！恒生创新药ETF华泰柏瑞（520500）成交放量，昨日成交环比增长超60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629962048","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629962048?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 11:27","pubTimestamp":1777001220,"startTime":"0","endTime":"0","summary":"近期，多重利空因素交织扰动市场，创新药板块迎来阶段性大幅回调。在此背景下，资金逆势布局意愿积极，港股创新药赛道配置价值有望持续凸显，恒生创新药ETF华泰柏瑞交投热度大幅攀升，成为助力资金布局板块核心工具之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2026-04-24/doc-inhvqmqe7999012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520500","06978","159992","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629896382","title":"港股异动 | 歌礼制药-B(01672)午前涨超4% 核心管线ASC30即将启动III期注册临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2629896382","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629896382?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 11:10","pubTimestamp":1777000213,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，歌礼制药-B午前涨超4%，截至发稿，涨3.46%，报18.82港元，成交额2199.1万港元。消息面上，歌礼制药此前宣布启动ASC30_39FDC的临床开发，并计划于今年第三季度向美国FDA递交IND申请。口服剂型即将向FDA提交III期临床计划，公司预计将在2026年Q3正式启动。值得注意的是，智通财经APP在《歌礼制药-B：股价突破前高在即，场外资金为何选择观望？》中指出，礼来Orforglipron已于今年4月1日获FDA批准上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01672","BK4585","BK1161","BK1191","BK1574","III","BK4134","VXUS","01477","BK4588","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629707860","title":"什么情况？港股通创新药突遭重挫，龙头领跌12%！520880放量跌4.51%连失多根均线，加仓还是离场？","url":"https://stock-news.laohu8.com/highlight/detail?id=2629707860","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629707860?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 09:18","pubTimestamp":1776993480,"startTime":"0","endTime":"0","summary":"4月23日，港股继续调整，恒指放量连阴失守26000点。港股通创新药突遭急跌，100%创新药研发标的——港股通创新药ETF华宝收跌4.51%五连阴，失守10日、20日及半年线等3根均线。　　值得关注的是，520880全天宽幅溢价，且交投尤为活跃，全天成交3.8亿元，较上日激增逾95%。　　权重龙头多股重挫为主要拖累，前十成份股中仅石药集团逆市收涨1.71%，康方生物领跌12.66%，三生制药跌9.63%，信达生物、科伦博泰生物跌近6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-24/doc-inhvqfhn3227784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","159992","520880","VXUS","06978","BK4588","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629386747","title":"【湾区早参】香港最新失业率下跌至3.7%；一季度深圳口岸累计出入境人员超7300万人次","url":"https://stock-news.laohu8.com/highlight/detail?id=2629386747","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629386747?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 08:34","pubTimestamp":1776990892,"startTime":"0","endTime":"0","summary":"今年一季度，深圳口岸有12次单日客流突破100万人次，最高达109万人次，内地与港澳居民双向流动日益频密，外国人入境持续升温。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZTRlMTU1ZDUyYWE0NDQzMjc2MzgzOTI4MA==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1979836","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1214","CNHmain","BK1249","LU0702159343.USD","BK1175","BK1246","02600","BK1615","BK1142","BK1149","00081","MCNHmain","BK1555","LU1808992512.USD","BK1116","BK1617","BK1574","UCmain","01833","00638","BK1247","CYB","09969","BK1571","BK1513","09896","BK1592","LU0702159699.USD","09981","BK1219","BK1240","BK1568","MUCmain","LU1166156734.SGD","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629867820","title":"男子称用了10多年的学位证被告知“无效” 山东医药大学：正调查核实","url":"https://stock-news.laohu8.com/highlight/detail?id=2629867820","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629867820?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 08:12","pubTimestamp":1776989520,"startTime":"0","endTime":"0","summary":"据红星新闻报道，“用了十几年的学位证莫名其妙‘无效’了。”日前，展先生向红星新闻反映称，自己多年前从滨州医学院毕业后，凭借毕业证和学位证一直正常参加工作，却在去年换工作时突然被告知其学位证“无效”，导致无法顺利入职。几经了解，展先生从校方获悉，他的学位证“从未被授予”。为了弄清自己手中的学位证真假，展先生对自己进行了举报，希望能通过相关单位倒查的方式，证实学位证的真伪。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2021/08/22/5093511165863077154.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2021/08/22/5093511165863077154.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1776988980129651.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1776988980129651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["09939","159938","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629643518","title":"中国创新药“军团”领跑AACR年会","url":"https://stock-news.laohu8.com/highlight/detail?id=2629643518","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629643518?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 07:00","pubTimestamp":1776985200,"startTime":"0","endTime":"0","summary":"1907年的华盛顿，11位医生与科学家随手组建的“小圈子”，谁也没想到会演变成今天全球癌症研究领域最负盛名的盛会——美国癌症研究协会（AACR）。一百多年后的今天，AACR年会早已不只是一场学术会议，更是全球肿瘤研发的“晴雨表”和“风向标”。对中国生物医药产业而言，AACR也成为观察创新活力与国际化进程的最佳窗口。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604243716840281.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243716840281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","06978","159992","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027869","title":"加科思-B(01167)4月23日耗资约49.45万港元回购6.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027869","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027869?lang=zh_cn&edition=fundamental","pubTime":"2026-04-24 06:16","pubTimestamp":1776982602,"startTime":"0","endTime":"0","summary":"智通财经APP讯，加科思-B(01167)公布，2026年4月23日耗资约49.45万港元回购6.75万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","01167","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":1,"totalSize":243,"code":"91000000","status":"200"}]}}